MJN Neuroserveis, a CataloniaBio & HealthTech member, has obtained the CE mark certification for a non-invasive medical device to help people with epilepsy improve their quality of life, together with the notified body BSI Group.
"We have achieved the most important milestone of the project, the certification for commercialization in Europe. The entire MJN team would like to express our gratitude to all the people and entities that have helped us" says Salva Gutiérrez, co-founder and CEO-CFO at MJN.
In the coming months, MJN will launch the medical device on the market: in Spain through its websitemjn.cat/en and in the rest of Europe they are negotiating distribution agreements.
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
The results show that adenocarcinoma exhibits much more active and fun...
